{"id":"W1902231903","doi":"10.1089/jamp.2013.1037","title":"Acute Hyperkalemia Associated with Inhalation of a Potent ENaC Antagonist: Phase 1 Trial of GS-9411","year":2013,"lang":"en","type":"article","venue":"Journal of Aerosol Medicine and Pulmonary Drug Delivery","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"Gilead Sciences (Canada)","funders":"Gilead Sciences","keywords":"Hyperkalemia; Medicine; Placebo; Urine sodium; Tolerability; Urine; Internal medicine; Anesthesia; Adverse effect; Endocrinology; Gastroenterology; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006845557,0.0002049651,0.0009746889,0.0003211726,0.00005047443,0.000008727216,0.0001265056,0.00008794743,0.0001183766],"category_scores_gemma":[0.0005206037,0.0001276072,0.0001324416,0.0003376575,0.0004325332,0.0003882579,0.00004211134,0.0004075492,0.000001642045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007818262,"about_ca_system_score_gemma":0.0003005208,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001652882,"about_ca_topic_score_gemma":0.000006513248,"domain_scores_codex":[0.9972508,0.0001241861,0.001080421,0.0001735777,0.001092263,0.0002787453],"domain_scores_gemma":[0.9968252,0.0005154968,0.001030137,0.0001970559,0.001097861,0.0003343177],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1257551,0.002482368,0.007178727,0.0005638952,0.001433656,0.001274938,0.001171573,0.00003209122,0.803725,0.000005199724,0.008737596,0.04763984],"study_design_scores_gemma":[0.578137,0.1302467,0.04626621,0.02168642,0.006947415,0.00893403,0.009516233,0.005706677,0.1893438,0.0004170345,0.001559428,0.001239029],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940661,0.002411641,0.0001002802,0.002174834,0.0001693076,0.0006317364,0.0000267189,0.000007799098,0.0004116471],"genre_scores_gemma":[0.9966067,0.0019818,0.0006297583,0.0001171495,0.0003725346,0.000007852669,0.00003749655,0.00002089573,0.0002257987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6143812,"threshold_uncertainty_score":0.5203671,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01744542694325159,"score_gpt":0.2947888883588506,"score_spread":0.2773434614155991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}